Development of autologous blood cell therapies
نویسندگان
چکیده
منابع مشابه
Toward Personalized Cell Therapies: Autologous Menstrual Blood Cells for Stroke
Cell therapy has been established as an important field of research with considerable progress in the last years. At the same time, the progressive aging of the population has highlighted the importance of discovering therapeutic alternatives for diseases of high incidence and disability, such as stroke. Menstrual blood is a recently discovered source of stem cells with potential relevance for ...
متن کاملAutologous Blood Transfusion
بدون شک بی خطرترین روش انتقال خون در بسیاری از بیماران، انتقال خون اتولوگ (جمع آوری و تزریق مجدد خون یا محصولات خونی) به خود بیمار است. انتقال خون اتولوگ اولین بار در سال ۱۹۲۱ عنوان شد، اما تا سال ۱۹۶۰ که بای پس کرونرو سایر جراحی های قلب بصورت معمول درآمد، توجه چندانی بدان نمی شد. امروزه انتقال خون اتولوگ بعلت نگرانی زیاد جامعه در مورد گسترش ایدز، عمومیت دوباره کسب کرده است.
متن کاملRapid cell separation with minimal manipulation for autologous cell therapies
The ability to isolate specific, viable cell populations from mixed ensembles with minimal manipulation and within intra-operative time would provide significant advantages for autologous, cell-based therapies in regenerative medicine. Current cell-enrichment technologies are either slow, lack specificity and/or require labelling. Thus a rapid, label-free separation technology that does not aff...
متن کاملEvolutionarily stable anti-cancer therapies by autologous cell defection
UNLABELLED Game theory suggests an anti-cancer treatment based on the use of modified cancer cells that disrupt cooperation within the tumor. Cancer cells are harvested from the patient, the genes for the production of essential growth factors are knocked out in vitro and the cells are then reinserted in the tumor, where they lead to its collapse. BACKGROUND AND OBJECTIVES Current anti-cancer...
متن کاملCell based therapies in retinal diseases
Background Degenerative retinal diseases, including age related macular degeneration, glaucoma, and hereditary retinal dystrophies are major causes of blindness. The principal defect in these diseases is cell loss which is amenable to both cell based neuroprotective and neuroregenerative therapies. To briefly review the lines of research and potential candidates for cell based therapies among ...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Experimental Hematology
سال: 2016
ISSN: 0301-472X
DOI: 10.1016/j.exphem.2016.06.005